HER2 EXPRESSING SOLID TUMORS
Clinical trials for HER2 EXPRESSING SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new HER2 EXPRESSING SOLID TUMORS trials appear
Sign up with your email to follow new studies for HER2 EXPRESSING SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene therapy takes aim at Hard-to-Treat HER2 cancers
Disease control Recruiting nowThis study tests a new gene therapy called VNX-202 for people with HER2-positive solid tumors. The therapy uses a harmless virus to deliver instructions that help the body's immune cells attack cancer. The trial has two parts: one for advanced cancers that have stopped responding…
Matched conditions: HER2 EXPRESSING SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Vironexis Biotherapeutics Inc. • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
New mRNA drug takes on HER2 cancers in first human trial
Disease control Recruiting nowThis early-stage trial is testing a new mRNA-based drug called MT-304, alone or with the immunotherapy nivolumab, in adults with advanced HER2-expressing solid tumors. The main goals are to check safety, find the right dose, and get a first look at whether it shrinks tumors. Abou…
Matched conditions: HER2 EXPRESSING SOLID TUMORS
Phase: PHASE1 • Sponsor: Myeloid Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC